Trial Profile
Prospective single-centre cohort study assessing immunogenicity and clinical outcomes of adalimumab treatment in inflammatory bowel disease patients who have switched from infliximab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab
- Indications Inflammatory bowel diseases
- Focus Pharmacodynamics; Therapeutic Use
- 08 Dec 2015 New trial record